Royal Bank of Canada »

Nervgen Pharma Ord shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Nervgen Pharma Ord (NGENF) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Nervgen Pharma Ord

Tip: Access up to 7 years of quarterly data

All positions including Nervgen Pharma Ord held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nervgen Pharma Ord by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2026-03-31 $648k 172k 3.77

More positions owned by Royal Bank of Canada

Apple (AAPL)
NVIDIA Corporation (NVDA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Bank Of Montreal Cadcom (BMO)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Cibc Cad (CM)
Canadian Natural Resources (CNQ)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Royal Bank of Canada

Top funds holding Nervgen Pharma Ord

PFG Investments
Bank of America Corporation
Marshall Wace
Royal Bank of Canada
Integrated Wealth Concepts
Valley Forge Investment Consultants Inc Adv
Bank Of Montreal
Captrust Financial Advisors
UBS Group
Advisor Group Holdings
Patriot Financial Group Insurance Agency
Commonwealth Equity Services
Cetera Investment Advisers
McKinley Carter Wealth Services
Traynor Capital Management

View all funds holding Nervgen Pharma Ord